SUANNUTRA and Myota Partner to Deliver Precision Prebiotic Solutions Across US, UK, and EU

Myota's Metabolic Regulator offers precision-formulated, science-backed prebiotic fibers to support healthy metabolism

BARCELONA, Spain, May 13, 2025 /PRNewswire/ -- SUANNUTRA, a global leader in nutraceutical ingredients, has entered an exclusive distribution agreement with UK-based Myota to launch its clinically backed prebiotic fiber blends—including the flagship Metabolic Regulator—across the US, UK, and EU^[1].

At the heart of this collaboration lies a powerful scientific synergy: Myota's patented blend of nine plant-based fibres promotes the direct production of beneficial short-fatty acids (SCFAs) through targeted fermentation by gut microbiota. SUANNUTRA's flagship ingredient, Metabolaid®, complements this effect by indirectly supporting SCFA generation via microbiome modulation. These SCFAs play a key role in the stimulation of GLP-1. In addition, Metabolaid® activates AMPK pathway and helping maintain healthy lipid metabolism and blood pressure levels. Together, these technologies deliver a synergistic, multi-pathway approach to metabolic health - enhancing prebiotic action at the gut level and supporting systemic metabolic balance.

Metabolic Regulator has been studied for supporting healthy blood sugar levels, maintaining cholesterol already within a normal range, and minimising postprandial glucose spikes with evidence drawn from MIT research and third-party clinical trials. Its low-FODMAP, clean-label formulation is suitable even for those with digestive sensitivities.

"This partnership enhances our portfolio with targeted microbiome-nourishing solutions, providing next-gen support for cardiometabolic wellness," said Anthony Weston, CEO of SUANNUTRA. "By combining Metabolaid®'s support of key metabolic pathways with Myota's microbiome-driven prebiotic approach, we're delivering a complementary dual-action approach to today's metabolic health needs."

Thomas Gurry, PhD, CEO of Myota, added: "We see immense value in pairing our fermentation-optimized prebiotics with SUANNUTRA's clinically vetted actives. Together, we are shifting the paradigm from generic gut health to precision-formulated, systemic wellness."

The full range, including blends for immune and digestive health, will debut at Vitafoods Europe 2025 (May 20–22, Booth #3K22). Custom blends and formulation support will also be available through SUANNUTRA.

About SUANNUTRA and Myota

About SUANNUTRA

SUANNUTRA is a Global leading nutraceutical ingredient player, offering a growing portfolio of scientifically backed, clinically proven branded & functional ingredient sourcing. SUANNUTRA boasts more than 22 clinical studies, and 6 awards won across a proprietary and scientifically endorsed, branded ingredients portfolio addressing the Weight Management, Beauty from Within and Women's Health segments, by leveraging innovative science and underpinned by a strong pipeline.

About Myota

Founded in 2019, Myota develops clean-label, low-FODMAP prebiotic blends grounded in nearly a decade of research at MIT. Focused on tailoring fiber blends to individual microbiome profiles, Myota ensures maximum fermentation efficiency and clinical efficacy—bridging gut and metabolic health.

^1. Excludes Germany and Austria.

Photo: https://mma.prnewswire.com/media/2686008/SUANNUTRA_and_Myota_Partner.jpg

For more information, please contact:

SUANNUTRA
Website: suannutra.com
Email: [email protected] 

Myota
Website: myotahealth.com
Email: [email protected] 

Press Contact
NutriPR
Liat Simha 
Email: [email protected] 
Tel.: +972-9-9742893

SOURCE SUANNUTRA; Myota